The drug agency requires that the unused investigational agents are expected to be returned to the sponsor at the termination site visit.
This refers to the final monitoring visit of the agent after all subjects have completed the study and data are recorded in case report forms.
Hence, the drug agency requires that the unused investigational agents are expected to be returned to the sponsor at the termination site visit.
Read more about site visit
brainly.com/question/16148816
#SPJ12
